- Home
- APLT vs LITB Comparison
APLT vs LITB Comparison
Compare APLT & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- LITB
- Stock Information
- Founded
- APLT 2016
- LITB 2007
- Country
- APLT United States
- LITB Singapore
- Employees
- APLT N/A
- LITB N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- LITB Catalog/Specialty Distribution
- Sector
- APLT Health Care
- LITB Consumer Discretionary
- Exchange
- APLT Nasdaq
- LITB Nasdaq
- Market Cap
- APLT 37.5M
- LITB 32.7M
- IPO Year
- APLT 2019
- LITB N/A
- Fundamental
- Price
- APLT $0.40
- LITB $1.21
- Analyst Decision
- APLT Buy
- LITB
- Analyst Count
- APLT 7
- LITB 0
- Target Price
- APLT $6.10
- LITB N/A
- AVG Volume (30 Days)
- APLT 1.9M
- LITB 30.6K
- Earning Date
- APLT 05-20-2025
- LITB 05-27-2025
- Dividend Yield
- APLT N/A
- LITB N/A
- EPS Growth
- APLT N/A
- LITB N/A
- EPS
- APLT N/A
- LITB N/A
- Revenue
- APLT $455,000.00
- LITB $255,287,000.00
- Revenue This Year
- APLT $1,768.13
- LITB N/A
- Revenue Next Year
- APLT $361.28
- LITB N/A
- P/E Ratio
- APLT N/A
- LITB N/A
- Revenue Growth
- APLT N/A
- LITB N/A
- 52 Week Low
- APLT $0.30
- LITB $0.91
- 52 Week High
- APLT $10.62
- LITB $6.00
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- LITB 38.45
- Support Level
- APLT $0.39
- LITB $1.15
- Resistance Level
- APLT $0.44
- LITB $1.34
- Average True Range (ATR)
- APLT 0.04
- LITB 0.19
- MACD
- APLT 0.01
- LITB -0.05
- Stochastic Oscillator
- APLT 45.49
- LITB 14.07
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.